Patents by Inventor Yong-In Kim

Yong-In Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for antibodies targeting complement protein C5
    Patent number: 10407496
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: September 10, 2019
    Assignee: Novartis AG
    Inventors: Beate Diefenbach-Streiber, Adina Eberth, Braydon Charles Guild, Yong-In Kim, Michael Roguska, Igor Splawski
  • CHOCOLATE COMPOSITION HAVING IMPROVED PROCESSABILITY, AND PREPARATION METHOD THEREFOR
    Publication number: 20190269140
    Abstract: The present invention relates to chocolate containing allulose and a method of preparing thereof, and more specifically, provides a chocolate composition having reduction of saccharides added to chocolate, masking of bitter taste of chocolate and excellent emulsion stability, and a method of preparing thereof.
    Type: Application
    Filed: October 31, 2017
    Publication date: September 5, 2019
    Applicant: SAMYANG CORPORATION
    Inventors: Il SEO, Bong Chan KIM, Yong-In KIM, Seung Mi LEE, Su Youn LIM, Hye Jin LIM, Tae-Chul HAN, Jung Sook HAN
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P
    Publication number: 20180327486
    Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).
    Type: Application
    Filed: May 7, 2018
    Publication date: November 15, 2018
    Applicant: Novartis AG
    Inventors: Leslie Ngozi Anuna JOHNSON, Ute JAEGER, Yong-In KIM, Christian Carsten Silvester KUNZ, Igor SPLAWSKI, Michael ROGUSKA, Joy GHOSH, Barbara BRANNETTI, Michael STEFANIDAKIS, Sha-Mei LIAO
  • HUMANIZED OR AFFINITY-MATURED ANTI ANG-2 ANTIBODY AND USES THEREOF
    Publication number: 20180273613
    Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.
    Type: Application
    Filed: June 11, 2018
    Publication date: September 27, 2018
    Inventors: Seok Kyun Kim, Sunghyun Kim, Sang Yeul Han, Seung Hyun Lee, Su Jin Kim, Yong In Kim, Hyung-Chan Kim, Kwang Hoon Lee, Hyo Seon Lee
  • Angiopoietin-2 specific antibodies and uses thereof
    Patent number: 10047154
    Abstract: An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: August 14, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Seok Kyun Kim, Sang Yeul Han, Kwang Hoon Lee, Kyung Eun Kim, Chung Ho Kim, Yong In Kim, Hyung-Chan Kim, Yoon Sook Lee, Hyo Seon Lee
  • Humanized or affinity-matured anti Ang-2 antibody and uses thereof
    Patent number: 9994632
    Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: June 12, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Seok Kyun Kim, Sunghyun Kim, Sang Yeul Han, Seung Hyun Lee, Su Jin Kim, Yong In Kim, Hyung-Chan Kim, Kwang Hoon Lee, Hyo Seon Lee
  • Compositions comprising antibodies targeting factor P
    Patent number: 9988440
    Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: June 5, 2018
    Assignee: NOVARTIS AG
    Inventors: Leslie Ngozi Anuna Johnson, Ute Jaeger, Yong-In Kim, Christian Carsten Silvester Kunz, Igor Splawski, Michael Roguska, Joy Ghosh, Barbara Brannetti, Michael Stefanidakis, Sha-Mei Liao
  • Compositions and Methods for Antibodies Targeting Complement Protein C5
    Publication number: 20170260260
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Application
    Filed: November 17, 2016
    Publication date: September 14, 2017
    Inventors: Beate DIEFENBACH-STREIBER, Adina EBERTH, Braydon Charles GUILD, Yong-In KIM, Michael ROGUSKA, Igor SPLAWSKI
  • Compositions and Methods for Antibodies Targeting Complement Protein C5
    Publication number: 20160031975
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Application
    Filed: April 28, 2015
    Publication date: February 4, 2016
    Applicant: NOVARTIS AG
    Inventors: Beate DIEFENBACH-STREIBER, Adina EBERTH, Braydon Charles GUILD, Yong-In KIM, Michael ROGUSKA, Igor SPLAWSKI
  • HUMANIZED OR AFFINITY-MATURED ANTI ANG-2 ANTIBODY AND USES THEREOF
    Publication number: 20150337033
    Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 26, 2015
    Inventors: Seok Kyun Kim, Sunghyun Kim, Sang Yeul Han, Seung Hyun Lee, Su Jin Kim, Yong In Kim, Hyung-Chan Kim, Kwang Hoon Lee, Hyo Seon Lee
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P
    Publication number: 20150158936
    Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).
    Type: Application
    Filed: June 19, 2014
    Publication date: June 11, 2015
    Applicant: NOVARTIS AG
    Inventors: Leslie Ngozi Anuna Johnson, Ute Jaeger, Yong-In Kim, Christian Carsten Silvester KUNZ, Igor Splawski, Michael Roguska, Joy Ghosh, Barbara Brannetti, Michael Stefanidakis, Sha-Mei Liao
  • Antibodies that bind factor P
    Patent number: 9051365
    Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: June 9, 2015
    Assignee: Novartis AG
    Inventors: Leslie Ngozi Anuna Johnson, Ute Jaeger, Yong-In Kim, Christian Carsten Silvester Kunz, Igor Splawski, Michael Roguska, Joy Ghosh, Barbara Brannetti, Sha-Mei Liao, Michael Stefanidakis
  • ANGIOPOIETIN-2 SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20150037343
    Abstract: An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.
    Type: Application
    Filed: July 30, 2014
    Publication date: February 5, 2015
    Inventors: Seok Kyun KIM, Sang Yeul Han, Kwang Hoon Lee, Kyung Eun Kim, Chung Ho Kim, Yong In Kim, Hyung-Chan Kim, Yoon Sook Lee, Hyo Seon Lee
  • Compositions and methods for antibodies targeting complement protein C5
    Patent number: 8883158
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: November 11, 2014
    Assignee: Novartis AG
    Inventors: Beate Diefenbach-Streiber, Adina Eberth, Braydon Charles Guild, Yong-In Kim, Michael Roguska, Igor Splawski
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P
    Publication number: 20130295102
    Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).
    Type: Application
    Filed: December 17, 2012
    Publication date: November 7, 2013
    Inventors: Leslie Ngozi Anuna Johnson, Ute Jaeger, Yong-In Kim, Christian Carsten Silvester Kunz, Igor Splawski, Michael Roguska, Joy Ghosh, Barbara Brannetti
  • Compositions and Methods for Antibodies Targeting Complement Protein C5
    Publication number: 20130064836
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Application
    Filed: July 25, 2012
    Publication date: March 14, 2013
    Inventors: Beate DIEFENBACH-STREIBER, Adina EBERTH, Braydon Charles GUILD, Yong-In KIM, Michael ROGUSKA, Igor SPLAWSKI
  • Compositions and Methods for Antibodies Targeting Complement Protein C5
    Publication number: 20130022615
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Application
    Filed: June 28, 2012
    Publication date: January 24, 2013
    Inventors: Beate DIEFENBACH-STREIBER, Adina EBERTH, Braydon Charles GUILD, Yong-In KIM, Michael ROGUSKA, Igor SPLAWSKI
  • Compositions and methods for antibodies targeting complement protein C5
    Patent number: 8241628
    Abstract: The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: August 14, 2012
    Assignee: Novartis AG
    Inventors: Beate Diefenbach-Streiber, Adina Eberth, Braydon Charles Guild, Yong-In Kim, Michael Roguska, Igor Splawski
  • COMMUNICATION APPARATUS AND METHOD
    Publication number: 20110188542
    Abstract: A communication apparatus and method for operating a communication apparatus are provided. The communication apparatus is configured to determine whether a sub-frequency band causing interference is present among sub-frequency bands included in a reception frequency band group, and to send to another communication apparatus an interference avoidance request signal which requests the other communication apparatus to transmit signals by use of remaining sub-frequency bands except the sub-frequency band causing interference, leading to simpler and more efficient interference avoidance.
    Type: Application
    Filed: January 10, 2011
    Publication date: August 4, 2011
    Applicant: PANTECH CO., LTD.
    Inventors: Young-Jun PARK, Mun-Se KIM, Min-Cheol KIM, Yong-In KIM, Hyun-Kuk KIM
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B
    Publication number: 20100291106
    Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind to both human and cynomolgus complement protein C3b, as well as compositions and methods of use thereof.
    Type: Application
    Filed: May 4, 2010
    Publication date: November 18, 2010
    Inventors: Bijan Etemad-Gilbertson, Braydon Charles Guild, Yong-In Kim, Ingo Klagge, Alexandra Kraus, Michael Roguska, Igor Splawski, Kehao Zhao